ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
Abstract Background It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important regulator of lipid metabolism. In this study, we explored how ANGPTL3 impacts dyslipidemia during PNS developm...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2022-04-01
|
| Ráidu: | Lipids in Health and Disease |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1186/s12944-022-01632-y |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
